By Dani Blum I’ve reported on Ozempic since 2022. New research shows that semaglutide, the compound in the weight-loss drug Wegovy, could treat an increasingly common liver disease. The study ...

"It’s a struggle to stay in business right now as it is, and if you take the semaglutide injections away, it will definitely make things a lot tighter to stay in business," she said. Compound ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...

503A compounding pharmacies may continue to compound semaglutide injection products until April 22, 2025. 503B outsourcing facilities may continue to compound semaglutide injection products until ...

Semaglutide effectively treats liver disease in two thirds of patients, new research has found. Results from the ESSENCE phase 3 clinical trial published today in the New England Journal of ...

Learn more › Ready to transform your body before summer? It’s possible with the ShedRx 4-Week Semaglutide Weight Loss Program. It offers personalized care, telehealth consultations ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group. The Food and Drug Administration (FDA) has accepted for review ...

More than half of adults with MASH receiving semaglutide had resolution of steatohepatitis at 72 weeks. A reduction in liver fibrosis stage was observed among 36.8% of the semaglutide group.

A US judge has rejected efforts by a compounded drugs industry group to keep making an alternative version of Novo Nordisk’s popular drug semaglutide, opening the door for the US Food and Drug ...

The frequency of blurred vision and visual impairment was relatively high with both formulations of semaglutide; adverse drug events related to the retina were more common with subcutaneous ...